CDC Oct. 22 webinar on COVID-19 and patients with substance use disorder
The Centers for Disease Control and Prevention Oct. 22 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on improving clinicians’ understanding the relationship between COVID-19 and the concerns of people who use drugs or who have a substance use disorder.
Subject matter experts also will highlight existing resources and exceptions for clinicians who prescribe medications for opioid use disorder, existing community-based linkages to care resources and the outpatient telemedicine experience from the perspective of front-line providers. Join the webinar here using ID 160 928 8166. A recording will be available for viewing on the COCA Call webpage a few hours after the live event concludes.
Related News Articles
Headline
CDC issues reminder on ending of the emergency authorization for COVID-19 in vitro diagnostics tests
The Centers for Disease Control and Prevention issued a reminder Oct. 14 that the declaration supporting the emergency use of COVID-19 in vitro diagnostics…
Headline
A Centers for Disease Control and Prevention report highlights differences in substance use among U.S. high school students. The report, which combined data…
Headline
The Department of Health and Human Services Office for Civil Rights released new guidance on statutory and regulatory requirements under 42 CFR Part 2, which…
Headline
The Health Resources and Services Administration announced Sept. 25 that it awarded $89.3 million in grants to expand access to substance use disorder…
Headline
The Substance Abuse and Mental Health Services Administration Sept. 25 announced that it awarded $247.9 million in grants for services expanding access to…
Headline
The Substance Abuse and Mental Health Services Administration announced Sept. 18 that it awarded $42.3 million in grants to states and territories to support…